Identification of the insulin-responsive tyrosine phosphorylation sites on IRSp53

European Journal of Cell Biology

Volumn 87, Issue 8-9, 2008, Pages 699-708

  Heung, Man Yeung ^a   Visegrady, Balazs ^b   Fütterer, Klaus ^a   Machesky, Laura M ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Actin; Epidermal growth factor; Filopodia; Insulin receptor; IRSp53; Motility; Tyrosine phosphorylation

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; PROTEIN IRSP53; SOMATOMEDIN RECEPTOR; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL STRUCTURE; HUMAN; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; MUTANT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STIMULATION; WESTERN BLOTTING;

ACTINS; ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; COS CELLS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PSEUDOPODIA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TRANSFECTION; TYROSINE;

EID: 49249085903     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2008.02.010     Document Type: Article

References (21)

1. Alvarez C.E., Sutcliffe J.G., and Thomas E.A. Novel isoform of insulin receptor substrate p53/p58 is generated by alternative splicing in the CRIB/SH3-binding region. J. Biol. Chem. 277 (2002) 24728-24734
2. Disanza A., Mantoani S., Hertzog M., Gerboth S., Frittoli E., Steffen A., Berhoerster K., Kreienkamp H.J., Milanesi F., Di Fiore P.P., Ciliberto A., Stradal T.E., and Scita G. Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex. Nat. Cell Biol. 8 (2006) 1337-1347
3. El-Sibai M., Nalbant P., Pang H., Flinn R.J., Sarmiento C., Macaluso F., Cammer M., Condeelis J.S., Hahn K.M., and Backer J.M. Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells. J. Cell Sci. 120 (2007) 3465-3474
4. Funato Y., Terabayashi T., Suenaga N., Seiki M., Takenawa T., and Miki H. IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness. Cancer Res. 64 (2004) 5237-5244
5. Govind S., Kozma R., Monfries C., Lim L., and Ahmed S. Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin. J. Cell Biol. 152 (2001) 579-594
6. Hori K., Konno D., Maruoka H., and Sobue K. MALS is a binding partner of IRSp53 at cell-cell contacts. FEBS Lett. 554 (2003) 30-34
7. Krugmann S., Jordens I., Gevaert K., Driessens M., Vandekerckhove J., and Hall A. Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex. Curr. Biol. 11 (2001) 1645-1655
8. Mattila P.K., Pykalainen A., Saarikangas J., Paavilainen V.O., Vihinen H., Jokitalo E., and Lappalainen P. Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J. Cell Biol. 176 (2007) 953-964
9. Miki H., and Takenawa T. WAVE2 serves a functional partner of IRSp53 by regulating its interaction with Rac. Biochem. Biophys. Res. Commun. 293 (2002) 93-99
10. Miki H., Yamaguchi H., Suetsugu S., and Takenawa T. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature 408 (2000) 732-735
11. Millard T.H., Bompard G., Heung M.Y., Dafforn T.R., Scott D.J., Machesky L.M., and Futterer K. Structural basis of filopodia formation induced by the IRSp53/MIM homology domain of human IRSp53. EMBO J. 24 (2005) 240-250
12. Millard T.H., Dawson J., and Machesky L.M. Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties. J. Cell Sci. 120 (2007) 1663-1672
13. Miyahara A., Okamura-Oho Y., Miyashita T., Hoshika A., and Yamada M. Genomic structure and alternative splicing of the insulin receptor tyrosine kinase substrate of 53-kDa protein. J. Hum. Genet. 48 (2003) 410-414
14. Okamura-Oho Y., Miyashita T., and Yamada M. Distinctive tissue distribution and phosphorylation of IRSp53 isoforms. Biochem. Biophys. Res. Commun. 289 (2001) 957-960
15. Peter B.J., Kent H.M., Mills I.G., Vallis Y., Butler P.J., Evans P.R., and McMahon H.T. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science 303 (2004) 495-499
16. Soltau M., Richter D., and Kreienkamp H.J. The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42. Mol. Cell. Neurosci. 21 (2002) 575-583
17. Suetsugu S., Murayama K., Sakamoto A., Hanawa-Suetsugu K., Seto A., Oikawa T., Mishima C., Shirouzu M., Takenawa T., and Yokoyama S. The RAC binding domain/IRSp53-MIM homology domain of IRSp53 induces RAC-dependent membrane deformation. J. Biol. Chem. 281 (2006) 35347-35358
18. Torres E., and Rosen M.K. Protein-tyrosine kinase and GTPase signals cooperate to phosphorylate and activate Wiskott-Aldrich syndrome protein (WASP)/neuronal WASP. J. Biol. Chem. 281 (2006) 3513-3520
19. Warrens A.N., Jones M.D., and Lechler R.I. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 186 (1997) 29-35
20. Yamagishi A., Masuda M., Ohki T., Onishi H., and Mochizuki N. A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein. J. Biol. Chem. 279 (2004) 14929-14936
21. Yeh T.C., Ogawa W., Danielsen A.G., and Roth R.A. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase. J. Biol. Chem. 271 (1996) 2921-2928